Summer is in full swing
July has arrived and the summer is in full swing! ReBlood is excited to share all of the work we’ve done last month and what we have planned ahead. We hope everyone had a great June and is ready for an amazing July.
Thanks
Our team would like to thank Larta Institute’s Heal.LA program. The opportunity to be mentored by some of the most knowledgable industry experts has been invaluable to our growth as a company and founders. We look forward to continued collaboration and further conversations.
Achievements
- ReBlood would like to extend our appreciation to Mark Hudges, a Regulatory Consultant for Veterinarian Drug Development, for assisting us in the application for a significant fee waiver from the FDA, saving ReBlood Rx over $900,000 dollars!
- We are happy to announce that we have initiated the planning process to determine what our product will look like at scale, allowing for broader implementation.
- ReBlood Rx is excited to announce that we have progressed to Stage 2 of the VentureWell program, which will provide us additional support and resources to further our development and scaling efforts.
- Thank you to all who keep up with our journey on LinkedIn! If you are not following our page, visit us here to stay up to date!
Opportunities
- With all the potential partnerships on the horizon, ReBlood could use all the guidance and advice we can get. If you or anyone you know has experience navigating early-stage partnerships, we would appreciate any feedback.
- Now that we are pitching to potential investors, if you would like to review our deck or listen to our pitch and provide us with constructive feedback, please let us know!
- ReBlood Rx is eager to learn and grow! If you know of any accelerator opportunities, we would love to hear about them.
- ReBlood Rx is looking for help sourcing grants in the DoD, NSF, or NHLBI ecosystem. If you know of any please forward them over!
Thank you all for your continued support!